Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mark Richards

Showing results (81-90 of 390) with videos related to

Pageof 39
Sort By:
Hypertension (Dallas, Tex. : 1979)|November 2, 2002
Long-term adrenomedullin administration in experimental heart failureMiriam T Rademaker, Chris J Charles, Eric A Espiner, et al.
Clinical Chemistry|April 22, 2017
Development of a BNP1-32 Immunoassay That Does Not Cross-React with proBNPLynley K Lewis, Sara D Raudsepp, Tim G Yandle, et al.
The Journal of Endocrinology|February 7, 2007
Characterisation of proghrelin peptides in mammalian tissue and plasmaAngela S Bang, Steven G Soule, Tim G Yandle, et al.
Peptides|August 12, 2009
Skeletal contributions to plasma CNP forms: evidence from regional sampling in growing lambsTimothy C R Prickett, Chris J Charles, Timothy G Yandle, et al.
Journal of the American College of Cardiology|August 17, 2019
Hemodynamic, Hormonal, and Renal Actions of Phosphodiesterase-9 Inhibition in Experimental Heart FailureNicola J A Scott, Miriam T Rademaker, Christopher J Charles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 5, 2019
Associations of Gout and Baseline Serum Urate Level With Cardiovascular Outcomes: Analysis of the Coronary Disease Cohort StudyLisa K Stamp, Christopher Frampton, Jill Drake, et al.
Clinical Science (London, England : 1979)|October 9, 2007
Direct cardiac actions of erythropoietin (EPO): effects on cardiac contractility, BNP secretion and ischaemia/reperfusion injuryJarkko Piuhola, Risto Kerkelä, Jacqueline I Keenan, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 12, 2008
Human cerebral arteriovenous vasoactive exchange during alterations in arterial blood gasesKaren C Peebles, A Mark Richards, Leo Celi, et al.
JACC. Heart Failure|March 14, 2014
Urocortin-2 infusion in acute decompensated heart failure: findings from the UNICORN study (urocortin-2 in the treatment of acute heart failure as an adjunct over conventional therapy)W Y Wandy Chan, Christopher M Frampton, Ian G Crozier, et al.
Hypertension (Dallas, Tex. : 1979)|July 22, 2009
Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac functionSuetonia C Palmer, Timothy C R Prickett, Eric A Espiner, et al.
Pageof 39

Showing results (81-90 of 390) with videos related to

Sort By:
Pageof 39
Hypertension (Dallas, Tex. : 1979)|November 2, 2002
Long-term adrenomedullin administration in experimental heart failureMiriam T Rademaker, Chris J Charles, Eric A Espiner, et al.
Clinical Chemistry|April 22, 2017
Development of a BNP1-32 Immunoassay That Does Not Cross-React with proBNPLynley K Lewis, Sara D Raudsepp, Tim G Yandle, et al.
The Journal of Endocrinology|February 7, 2007
Characterisation of proghrelin peptides in mammalian tissue and plasmaAngela S Bang, Steven G Soule, Tim G Yandle, et al.
Peptides|August 12, 2009
Skeletal contributions to plasma CNP forms: evidence from regional sampling in growing lambsTimothy C R Prickett, Chris J Charles, Timothy G Yandle, et al.
Journal of the American College of Cardiology|August 17, 2019
Hemodynamic, Hormonal, and Renal Actions of Phosphodiesterase-9 Inhibition in Experimental Heart FailureNicola J A Scott, Miriam T Rademaker, Christopher J Charles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 5, 2019
Associations of Gout and Baseline Serum Urate Level With Cardiovascular Outcomes: Analysis of the Coronary Disease Cohort StudyLisa K Stamp, Christopher Frampton, Jill Drake, et al.
Clinical Science (London, England : 1979)|October 9, 2007
Direct cardiac actions of erythropoietin (EPO): effects on cardiac contractility, BNP secretion and ischaemia/reperfusion injuryJarkko Piuhola, Risto Kerkelä, Jacqueline I Keenan, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 12, 2008
Human cerebral arteriovenous vasoactive exchange during alterations in arterial blood gasesKaren C Peebles, A Mark Richards, Leo Celi, et al.
JACC. Heart Failure|March 14, 2014
Urocortin-2 infusion in acute decompensated heart failure: findings from the UNICORN study (urocortin-2 in the treatment of acute heart failure as an adjunct over conventional therapy)W Y Wandy Chan, Christopher M Frampton, Ian G Crozier, et al.
Hypertension (Dallas, Tex. : 1979)|July 22, 2009
Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac functionSuetonia C Palmer, Timothy C R Prickett, Eric A Espiner, et al.
Pageof 39